Anti-TNF certolizumab pegol induces antioxidant response in human monocytes via reverse signaling

BACKGROUND: Anti TNF drugs have been widely used in rheumatoid arthritis (RA) but only 70 to 80 % of patients respond to this therapy. Exploring the mode of action of anti-TNF drugs remains important in order to improve the efficiency of the treatment and enhance our knowledge of inflammation. TNF-α...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Arthritis Res Ther
Päätekijät: Boyer, Jean Frédéric, Baron, Michel, Constantin, Arnaud, Degboé, Yannick, Cantagrel, Alain, Davignon, Jean-Luc
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2016
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4774095/
https://ncbi.nlm.nih.gov/pubmed/26932562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-016-0955-8
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia